Connect with us

Technology

BreakBio, the Third Player in Personalized Drugs, Enters the Clinic

Published

on

MIAMI, Aug. 24, 2026 /PRNewswire/ — BreakBio, the third player in personalized drugs after Moderna and BioNTech and the top private company in the personalized drugs space with advanced cutting-edge technology, is entering the clinic next quarter. BreakBio aims to be not first-in-class but best-in-class. It is designed for both higher efficacy than Moderna or BioNTech and it is also designed to treat more cancer indications than Moderna or BioNTech.

BreakBio, the Third Player in Personalized Drugs, Enters the Clinic

BreakBio is designed for higher efficacy than Moderna’s individualized neoantigen therapy (INT). Higher efficacy because BreakBio is designed to find better targets per patient. It is an AI first biotech company. For every patient, its platform integrates highest quality tumor DNA sequencing, RNA sequencing, mass-spectrometry-based immunopeptidomics (of that patient) with proprietary deep AI analysis to find better targets on that patient’s cancer cells. Better targets means killing more (or all) of the cancer cells.BreakBio is designed to extend personalized drugs to more cancer indications than Moderna. BreakBio achieves this by targeting not just neoantigens (associated with mutations as Moderna and BioNTech do) but it also searches for and finds, in each patient, some of the hundreds of cancer-associated non-mutated proteins such as cancer testis antigens, embryonic antigens, etc. – so BreakBio is designed to also work for low mutational cancers, which means it is designed to work for all solid cancers both high mutational cancers like melanoma and low mutational cancers like colorectal.

About BreakBio:

BreakBio is a new generation of personalized cancer drugs designed to deliver both greater efficacy per patient and treat a broader range of cancers than today’s individualized neoantigen therapy competitor. The company combines mass spectrometry, machine learning, and its proprietary AI platform to design and manufacture individualized peptide-based medicines tailored to each patient’s cancer and combines them with approved cancer therapies to drive deeper and more durable anti-tumor responses.

Unlike approaches focused only on mutation-related neoantigen targets found in high-mutational cancers like melanoma, BreakBio targets neoantigens, but also targets non-mutated antigens (found by its AI platform per patient) in order to broaden the treatment to all solid tumors.

Media Contact:
Kim Nancarrow
COO/CFO
BreakBio Corp.
info@breakbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/breakbio-the-third-player-in-personalized-drugs-enters-the-clinic-302858746.html

SOURCE BreakBio Corp.

Continue Reading

Technology

/R E P E A T — Media Advisory – Parliamentary Secretary Hogan to deliver remarks at Scaling Up Conference/

Published

on

By

OTTAWA, ON, Nov. 17, 2026 /CNW/ — Corey Hogan, Parliamentary Secretary to the Minister of Energy and Natural Resources, will deliver remarks and participate in a panel discussion at Scaling Up, Canada’s industrial bioeconomy business conference. Open to media.  

Date: Thursday, November 19, 2026

Time: 8:15 a.m. ET

Accredited reporters from recognized media are welcome to attend Scaling Up 2026 on a complimentary basis. To request press credentials, email info@scalingupconference.ca.

Follow Natural Resources Canada on LinkedIn

SOURCE Natural Resources Canada

Continue Reading

Technology

Trip.com Group Limited to Report Third Quarter of 2026 Financial Results on December 1, 2026 U.S. Time

Published

on

By

SINGAPORE, Nov. 19, 2026 /PRNewswire/ — Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, will announce its financial results for the three months ended September 30, 2026 on Tuesday, December 1, 2026, U.S. Time, after the market closes.

Trip.com Group’s management team will host a conference call at 7:00 PM U.S. Eastern Time on December 1, 2026 (or 8:00 AM on December 2, 2026 in the Hong Kong Time) following the announcement.

The conference call will be available on Webcast live and replay at: http://investors.trip.com. The call will be archived for twelve months at this website.

All participants must pre-register to join this conference call using the Participant Registration link below:
https://register-conf.media-server.com/register/BI709a150ad7f14478b5e6a4b0f8ae0e9f.

Upon registration, each participant will receive details for this conference call, including dial-in numbers and a unique access PIN. To join the conference, please dial the number provided, enter your PIN, and you will join the conference instantly.

About Trip.com Group Limited

Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) is a leading global one-stop travel platform, integrating a comprehensive suite of travel products and services and differentiated travel content. It is the go-to destination for many travelers in Asia, and increasingly for travelers around the world, to explore travel, get inspired, make informed and cost-effective travel bookings, enjoy hassle-free on-the-go support, and share travel experience. Founded in 1999 and listed on Nasdaq in 2003 and HKEX in 2021, the Company currently operates under a portfolio of brands, including Ctrip, Qunar, Trip.com and Skyscanner, with the mission “to pursue the perfect trip for a better world.”

For further information, please contact:

Investor Relations
Trip.com Group Limited
Email: iremail@trip.com

View original content:https://www.prnewswire.com/news-releases/tripcom-group-limited-to-report-third-quarter-of-2026-financial-results-on-december-1-2026-us-time-302945070.html

SOURCE Trip.com Group Limited

Continue Reading

Technology

RAN Market Growth Accelerates in 3Q 2026, According to Dell’Oro Group

Published

on

By

Strongest Quarterly Growth in Nearly Five Years Reinforces RAN Stabilization Trend

REDWOOD CITY, Calif., Nov. 19, 2026 /PRNewswire/ — According to a recently published report from Dell’Oro Group, the trusted source for market information about the telecommunications, security, networks, and data center industries, the Radio Access Network (RAN) market continued to improve in the third quarter of 2026. Worldwide RAN revenue increased at a mid-single-digit rate year-over-year (Y/Y), marking the fastest quarterly growth in nearly five years and reinforcing the broader stabilization trend.

“The third quarter reinforces our view that the RAN market is stabilizing following more than two years of contraction,” said Stefan Pongratz, Vice President at Dell’Oro Group. “While the recovery remains uneven, the stronger-than-expected results and improving regional trends are encouraging. At the same time, the underlying fundamentals have not changed materially, and we continue to expect a relatively flat market over the next several years.”

Additional highlights from the 3Q 2026 RAN quarterly report:

Worldwide RAN revenues increased at a mid-single-digit rate Y/Y in 3Q26, slightly exceeding expectations and marking the strongest quarterly growth in nearly five years.

Regional performance was mixed, with robust growth in the Middle East and Africa (MEA) and Asia Pacific (APAC), excluding China, contributing to the stronger-than-expected results.

The competitive landscape remains highly concentrated. The top five RAN suppliers accounted for 97 percent of worldwide revenue in 3Q 2026.

The top five RAN suppliers by worldwide revenue remain Huawei, Ericsson, Nokia, ZTE, and Samsung. Relative to 2025, Ericsson’s 1Q26-3Q26 RAN revenue share is up approximately one percentage point, while Samsung is down over the same period.

Looking ahead, 2027 will be an important year for the industry as SpaceX potentially begins building out its terrestrial network and AI RAN deployments continue to scale. While these developments could reshape parts of the competitive landscape over time, their near-term impact on aggregate RAN spending is expected to be limited. Worldwide RAN revenues are projected to remain broadly flat in 2027, with a low-single-digit decline expected.

About the Report

Dell’Oro Group’s RAN Quarterly Report offers a complete overview of the RAN industry, with tables covering RAN market and/or supplier revenue for multiple RAN segments including 5G NR Sub-7 GHz, 5G NR mmWave, LTE, Macro BTS, Small Cells, Massive MIMO, and Cloud RAN. The report also tracks the RAN market by region and includes a four-quarter outlook. To purchase this report, please contact us by email at dgsales@delloro.com.

About Dell’Oro Group

Dell’Oro Group is a market research firm specializing in strategic competitive analysis of the telecommunications, security, enterprise networks, and data center infrastructure markets. Our firm provides in-depth quantitative data and qualitative analysis to facilitate critical, fact-based business decisions. For more information, contact Dell’Oro Group at +1.650.622.9400 or visit https://www.delloro.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ran-market-growth-accelerates-in-3q-2026-according-to-delloro-group-302944610.html

SOURCE Dell’Oro Group

Continue Reading

Trending